Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 3500
Single User License Price INR 248395
Corporate User License Price USD 5000
Corporate User License Price INR 354850
Site License Price USD 4000
Site License Price INR 283880
Request a Quote

Report Title

Molecular Diagnostics Market (US-specific Market Assessment) - Global Forecast upto 2024

Quote Request for License Type
License Type Price  
Single User License USD 3500
Site License USD 4000
Enterprise Wide License USD 5000
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Molecular Diagnostics Market (US-specific Market Assessment) - Global Forecast upto 2024


Quote Request for License Type
License Type Price  
Single User License USD 3500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Molecular Diagnostics Market (US-specific Market Assessment) - Global Forecast upto 2024

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Molecular Diagnostics Market (US-specific Market Assessment) - Global Forecast upto 2024



Executive Summary

Global Molecular Diagnostics Market (US-specific Market Assessment)-Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018-2024

Overview: Molecular diagnostics is the branch of clinical pathology or laboratory medicine that utilizes various molecular biology techniques to diagnose diseases, predict disease course, select treatments, and monitor the effectiveness of therapies. These tests are performed mainly to examine the existence of the disease in blood, tissue, or even in bones. The importance of nucleic acids and other cellular biomarkers in defining the vital cellular process has facilitated medical advancements in the diagnosis of various diseases. Early diagnosis of the disease is one of the key advantages of this technology. The capacity of molecular diagnostics to systematize molecular reactions for the enhancement of the clinical diagnosis has put healthcare in the front line. According to the estimation of the American Cancer Society, around 1,688,780 new cancer cases were diagnosed, and 600,920 people died due to cancer in 2017. According to the study by World Health Organization (WHO), approximately 14 million new cancer cases were diagnosed in 2017 and is expected to grow by about 70% over the next 2 decades. The outbreak of swine flu in Myanmar and India, in 2017, increased the demand for diagnosis in the Asia Pacific region. It is noticed that there is a considerable rise in the number of cases reported in 2017 when compared to 2016.

The market for molecular diagnostics is driven by increasing prevalence of infectious and other lifestyle diseases, increasing demand for non-invasive biomarker-based tests, growing adoption of point-of-care testing, and high growth of the market in emerging countries. Increasing number of mergers & acquisitions and growing significance of companion diagnostics are providing opportunities for the market growth. Low awareness about standardization, stringent regulatory approval process, and lack of skilled labors are hampering the market growth.

Market Analysis: The global molecular diagnostics market is estimated to witness a CAGR of 8.7% during the forecast period 2018-2024. The US occupied a dominant market share, i.e., 32% in 2017, and is expected to grow at a CAGR of 8.4% during the forecast period 2018-2024. The market is analyzed based on four segments-applications, technologies, end-users, and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder, followed by Europe, in the global molecular diagnostics market with the US contributing to significant market revenue. Increasing incidences of disease and organ transplantation in the US along with increasing funding by government & private players and increased adoption of personalized medicine in clinical practices are few of the factors driving the US molecular diagnostics market growth. Various countries in the Americas region are taking initiatives for the elimination of viral hepatitis, but the major challenge remains in the diagnosis of the disease. This is providing an opportunity for manufacturers to enhance their market presence. The Asia Pacific region is expected to witness the fastest growth rate due to the large patient pool, increasing awareness, and rising healthcare expenditure.

Technology Analysis: PCR occupied significant share in the global molecular diagnostics market in 2017. PCR is a gold standard technique for DNA amplification and is the primary technique conducted prior to any molecular diagnostic examination. Next-generation sequencing and microarray are expected to grow at the fastest rate during the forecast period.

Application Analysis: Among various application areas, the infectious disease application occupied the largest share in 2017 and cancer application is expected to grow at the highest growth rate during the forecast period. A large number of patients suffering from hospital-associated infection, sexually transmitted infection (STI), hepatitis, respiratory infection, pathogen ID detection, and others is fostering the market growth. Increasing incidence of cancer globally makes it the fastest growing application segment during the forecast period.

Key Players: F. Hoffmann-La Roche, Hologic, Inc., Danaher Corporation, Abbott Laboratories, and Siemens Healthineers Inc. are the key players in the market. Becton Dickenson and Company, bioMerieux S.A., Bio-Rad Laboratories, Inc., Qiagen NV, Grifols, S.A, Thermo Fisher Scientific, Sysmex Corporation, and Myriad Genetics are few predominate & niche players.

Competitive Analysis: Polymerase Chain Reaction (PCR) occupied a significant share in the molecular diagnostics market. The emerging players are focusing on developing NGS and microarray technology to have the edge in the market. The increasing importance of molecular diagnostic tests has resulted in the launch of new tests and also increased acquisition, strategic partnership, and funding to develop new tests and technologies. For instance, in April 2018, NanoString Technologies, Inc. launched a Breast Cancer 360 (BC 360) research panel. In July 2017, MDxHealth SA announced the commercial launch of its AssureMDx for bladder cancer test in the US as a laboratory developed test. Illumina recently started a new company, named GRAIL, for liquid biopsy. It invested USD 100 million and raised another USD 900 million through public funding to develop new non-invasive tests for cancer diagnosis.

Benefits: The report provides complete details about the usage and adoption rate of molecular diagnostics in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player's initiatives. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives the complete information about the key business opportunities to key stakeholders to analyze before investing or expanding the business in this market.

Key Stakeholders:

Table of Content

1 INDUSTRY OUTLOOK

1.1 Industry overview

1.2 Total addressable market

2 Report Outline

2.1 Report Scope

2.2 Report Summary

2.3 Research Methodology

2.4 Report Assumptions

3 Market Snapshot

3.1 Market Definition-Infoholic Research

3.2 Basic Steps of Molecular diagnostics

3.3 Segmented Addressable Market (SAM)

3.4 Major Trends in the Molecular Diagnostics Market

3.5 Related Markets

3.5.1 Liquid Biopsy

3.5.2 Point-of-Care diagnostics

3.5.3 Immunoassays

3.5.4 Clinical Chemistry

4 Market Outlook

4.1 Evolution iof Molecular Diagnostics

4.2 Market segmentation

4.3 PEST Analysis

4.4 Porter 5(Five) Forces

5 Market Characteristics

5.1 DRO-Global Molecular Diagnostics Market Dynamics

5.1.1 Drivers

5.1.1.1 Rising Prevalence of Infectious Disease

5.1.1.2 Growing Adoption of Point-of-care Testing

5.1.1.3 Increasing Demand for Biomarker-based Tests

5.1.1.4 High Growth of the Market in Emerging Countries

5.1.2 Opportunities

5.1.2.1 Growing Significance of Companion Diagnostics

5.1.2.2 Increase in Number of Mergers and Acquisitions

5.1.2.3 Increased Adoption of DNA Probe-based Diagnostics

5.1.3 Restraints

5.1.3.1 Stringent Regulatory Approvals

5.1.3.2 Lack of Skilled Labors

5.2 DRO-Impact Analysis

5.3 Key Stakeholders

6 Technology: Market Size and Analysis

6.1 Overview

6.2 PCR

6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)

6.4 Microarray

6.5 Hybridization

6.6 DNA sequencing

6.7 Others

7 Application: Market Size and Analysis

7.1 Overview

7.2 Oncology

7.2.1 Breast cancer

7.2.2 Colorectal cancer

7.2.3 Prostate cancer

7.2.4 Other cancers

7.3 Blood testing

7.4 Infectious Disease

7.5 Genetic Testing

7.6 Tissue Typing

7.7 Others

8 End Users: Market Size and Analysis

8.1 Overview

8.2 Hospitals

8.3 Reference Laboratories

8.4 Others

9 Regions: Market Size and Analysis

9.1 Overview

9.2 North America

9.3 Overview: US Molecular Diagnostics Market

9.4 Major Trends in the US Molecular Diagnostics Market

9.5 DRO-US Molecular Diagnostics Market Dynamics

9.6 Technology: US molecular Diagnostics Market

9.7 Application: US Molecular Diagnostics Market

9.8 Key companies of US molecular diagnostics market

9.9 Europe

9.9.1 UK 58

9.9.2 Germany

9.10 Asia Pacific

9.10.1 India

9.10.2 China

9.10.3 Japan

9.11 Rest of the World

9.11.1 Brazil

9.11.2 Mexico

9.11.3 Africa

10 Competitive Landscape

10.1 Overview

11 Vendor Profiles

11.1 Danaher Corporation

11.1.1 Overview

11.1.2 Business Units

11.1.3 Geographic Presence

11.1.4 Business Focus

11.1.5 SWOT Analysis

11.1.6 Business Strategies

11.2 F. Hoffmann-La Roche Ltd.

11.2.1 Overview

11.2.2 Business Units

11.2.3 Geographic Revenue

11.2.4 Business Focus

11.2.5 SWOT Analysis

11.2.6 Business Strategies

11.3 ABBOTT LABORATORIES

11.3.1 Overview

11.3.2 Business Unit

11.3.3 Geographic Presence

11.3.4 Business Focus

11.3.5 SWOT Analysis

11.3.6 Business Strategy

11.4 Hologic Inc.

11.4.1 Overview

11.4.2 Business Unit

11.4.3 Geographic Presence

11.4.4 Business Focus

11.4.5 SWOT Analysis

11.4.6 Business Strategy

11.5 Siemens Healthineers (Siemens AG)

11.5.1 Overview

11.5.2 Business Units

11.5.3 Geographic Presence

11.5.4 Business focus

11.5.5 SWOT analysis

11.5.6 Business Strategy

12 Companies to Watch For

12.1 Qiagen N.V.

12.1.1 Overview

12.2 Bio-Rad Laboratories

12.2.1 Overview

12.3 Myriad Genetics Inc.

12.3.1 Overview

12.4 Thermo Fisher Scientific

12.4.1 Overview

12.5 bioMerieux S.A.

12.5.1 Overview

12.6 Beckton Dickinson and Company

12.6.1 Overview

12.7 Grifols S.A.

12.7.1 Overview

12.8 Sysmex Corporation

12.8.1 Overview

13 Annexure

13.1 Abbreviations

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET 13

CHART 2 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE, 2017-2024 (USD MILLION) 17

CHART 3 SEGMENTATION OF GLOBAL MOLECULAR DIAGNOSTICS MARKET 20

CHART 4 PEST ANALYSIS OF GLOBAL MOLECULAR DIAGNOSTICS MARKET 21

CHART 5 PORTER 5 FORCES ON GLOBAL MOLECULAR DIAGNOSTICS MARKET 22

CHART 6 DRO-IMPACT ANALYSIS OF GLOBAL MOLECULAR DIAGNOSTICS MARKET 26

CHART 7 KEY STAKEHOLDERS OF MOLECULAR DIAGNOSTICS MARKET 27

CHART 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY SEGMENTATION, 2017 (%) 28

CHART 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION SEGMENTATION, 2017 (%) 32

CHART 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE IN ONCOLOGY SEGMENT, 2017-2024 (USD MILLION) 35

CHART 11 GLOBAL ONCOLOGY MARKET SHARE, 2017 (% SHARE) 36

CHART 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE IN BLOOOD TESTING SEGMENT, 2017-2024 (USD MILLION) 39

CHART 13 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE IN INFECTIOUS DISEASES SEGMENT, 2017-2024 (USD MILLION) 41

CHART 14 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE IN GENETIC TESTING SEGMENT, 2017-2024 (USD MILLION) 42

CHART 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE IN TISSUE TYPING SEGMENT, 2018-2024 (USD MILLION) 43

CHART 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE IN OTHER SEGMENTS, 2017-2024 (USD MILLION) 44

CHART 17 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END-USERS SEGMENTATION, 2017 (%) 45

CHART 18 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 48

CHART 19 MOLECULAR DIAGNOSTICS MARKET REVENUE IN NORTH AMERICA, 2017-2024 (USD MILLION) 50

CHART 20 MOLECULAR DIAGNOSTICS MARKET REVENUE IN THE US, 2017-2024 (USD MILLION) 52

CHART 21 US MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY SEGMENTATION, 2017 (%) 54

CHART 22 US MOLECULAR DIAGNOSTICS MARKET BY APPLICATION SEGMENTATION, 2017 (%) 56

CHART 23 MOLECULAR DIAGNOSTICS MARKET REVENUE IN EUROPE, 2017-2024 (USD MILLION) 57

CHART 24 MOLECULAR DIAGNOSTICS MARKET REVENUE IN ASIA PACIFIC, 2017-2024 (USD MILLION) 59

CHART 25 REST OF THE WORLD MARKET REVENUE IN REST OF THE WORLD, 2017-2024 (USD MILLION) 62

CHART 26 DANAHER CORPORATION: OVERVIEW SNAPSHOT 70

CHART 27 DANAHER CORPORATION: BUSINESS UNITS 71

CHART 28 DANAHER CORPORATION: GEOGRAPHIC PRESENCE 72

CHART 29 DANAHER CORPORATION: SWOT ANALYSIS 73

CHART 30 F. HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 81

CHART 31 F. HOFFMANN-LA ROCHE LTD.: BUSINESS UNITS 82

CHART 32 F. HOFFMANN-LA ROCHE LTD.: GEOGRAPHIC REVENUE 82

CHART 33 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 84

CHART 34 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 89

CHART 35 ABBOTT LABORATORIES.: BUSINESS UNITS 90

CHART 36 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 91

CHART 37 ABBOTT LABORATORIES: SWOT ANALYSIS 92

CHART 38 HOLOGIC INC.: OVERVIEW SNAPSHOT 96

CHART 39 HOLOGIC INC.: BUSINESS UNITS 97

CHART 40 HOLOGIC INC: GEOGRAPHIC PRESENCE 98

CHART 41 HOLOGIC, INC.: SWOT ANALYSIS 99

CHART 42 SIEMENS AG: OVERVIEW SNAPSHOT 103

CHART 43 SIEMENS AG: BUSINESS UNITS 104

CHART 44 SIEMENS AG: GEOGRAPHIC PRESENCE 105

CHART 45 SIEMENS HEALTHINEERS: SWOT ANALYSIS 106

Tables

TABLE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2017-2024 (USD MILLION) 34

TABLE 2 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE BY REGIONS, 2017-2024 (USD MILLION) 49

TABLE 3 OTHER PROMINENT VENDORS IN THE MARKET 65

TABLE 4 DANAHER CORPORATION: OFFERINGS 67

TABLE 5 DANAHER CORPORATION: RECENT DEVELOPMENTS 69

TABLE 6 F. HOFFMANN-LA ROCHE LTD.: PRODUCT OFFERINGS 75

TABLE 7 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 78

TABLE 8 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 85

TABLE 9 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 87

TABLE 10 HOLOGIC INC.: PRODUCT OFFERINGS 93

TABLE 11 HOLOGIC INC: RECENT DEVELOPMENTS 94

TABLE 12 SIEMENS HEALTHINEERS: PRODUCT OFFERINGS 101

TABLE 13 SIEMENS HEALTHINEERS: RECENT DEVELOPMENTS 102

TABLE 14 QIAGEN N.V.: SNAPSHOT 108

TABLE 15 QIAGEN N.V.: RECENT DEVELOPMENTS 108

TABLE 16 BIO-RAD LABORATORIES: SNAPSHOT 112

TABLE 17 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS 112

TABLE 18 MYRIAD GENETICS: SNAPSHOT 114

TABLE 19 MYRIAD GENETICS: RECENT DEVELOPMENTS 114

TABLE 20 THERMO FISHER SCIENTIFIC: SNAPSHOT 116

TABLE 21 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 116

TABLE 22 BIOMERIEUX S.A.: SNAPSHOT 120

TABLE 23 BIOMERIEUX S.A.: RECENT DEVELOPMENTS 121

TABLE 24 BECTON DICKINSON AND COMPANY: SNAPSHOT 123

TABLE 25 BECTON DICKENSON AND COMPANY: RECENT DEVELOPMENTS 124

TABLE 26 GRIFOLS S.A.: SNAPSHOT 125

TABLE 27 GRIFOLS, S.A.: RECENT DEVELOPMENTS 125

TABLE 28 SYSMEX CORPORATION: SNAPSHOT 127

TABLE 29 SYSMEX CORPORATION: RECENT DEVELOPMENTS 127

growing application segment during the forecast period.

Key Players: F. Hoffmann-La Roche, Hologic, Inc., Danaher Corporation, Abbott Laboratories, and Siemens Healthineers Inc. are the key players in the market. Becton Dickenson and Company, bioMerieux S.A., Bio-Rad Laboratories, Inc., Qiagen NV, Grifols, S.A, Thermo Fisher Scientific, Sysmex Corporation, and Myriad Genetics


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person